Abstract
Although EQ-5D has been used in the context of acute cough/lower respiratory tract infections (acute cough/LRTI), it has not been formally validated in this disease area. The primary aim of this study is to assess the construct validity of EQ-5D as a measure for economic evaluation in the context of acute cough/lower respiratory tract infections. Data were collected alongside an observational study of the management of patients with acute cough/LRTI in thirteen European countries. However, the analysis was limited to 349 patients from the UK. Hypotheses were specified a priori and tested in order to establish the construct validity of EQ-5D. Statistical methods used to test the a priori hypotheses included Wilcoxon signed rank sum test, Kruskal-Wallis test, Chi-square test and regression analysis. Most of the relationships that were tested were in line with the a priori hypotheses. The main results indicate that there was a negative relationship between symptom severity scores and EQ-5D, smoking was associated with worse EQ-5D scores and EQ-5D was able to discriminate between patients with headache, interference with normal activities and disturbed sleep. This study also showed that the EQ-5D is moderately responsive in patients with acute cough/LRTI, and is a suitable measure for use in economic evaluation studies of acute cough/LRTI
Similar content being viewed by others
References
Allin, D., James, I., Zachariah, J., Carr, W., Cullen, S., Middleton, A., et al. (2001). Comparison of once-and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infections. Clinical Therapeutics, 23(12), 1958–1968.
Badia, X., & Herdman, M. (2001). The importance of health-related quality-of-life data in determining the value of drug therapy. Clinical Therapeutics, 23(1), 168–175.
Barton, G. R., Bankart, J., Davis, A. C., & Summerfield, Q. A. (2004). Comparing utility scores before and after hearing-aid provision: results according to the EQ-5D, HUI3 and SF-6D. Applied Health Economics and Health Policy, 3(2), 103–105.
Brazier, et al. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271–292.
Brazier, et al. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13, 873–884.
Briggs et al. (2009). Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study European respiratory journal doi:10.1183/09031936.00153108
Brouwer, et al. (2008). Welfarism vs. extra-welfarism. Journal of Health Economics, 27(2), 325–338.
Butler, C. C., Hood, K., Hood, K., Verheij, T., Little, P., Melbye, H., et al. (2009). Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ, 338, b2242.
Cleemput, et al. (2004). The construct and concurrent validity of EQ-5D in a renal transplant population. Value in Health, 7(4), 499–509.
Drummond, M. F., Sculpher, M. J., Torrance, G. W., O’brien, B. J., & Stoddart, G. L. (2005). Methods for the economic evaluation of health care programmes. USA: Oxford University Press.
Fransen, M., & Edmonds, J. (1999). Reliability and validity of the EuroQol in patients with osteoarthritis of the knee. Rheumatology, 38(9), 807.
Furlong, et al. (2001). The health utilities index (HUI) system for assessing health related quality of life in clinical studies. Annals of Medicine, 33(5), 375–384.
Gold, M. R. (1996). Cost-effectiveness in health and medicine. USA: Oxford University Press.
Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622.
Haywood, K. L., Garratt, A. M., Lall, R., Smith, J. F., & Lamb, S. E. (2008). EuroQol EQ-5D and condition-specific measures of health outcome in women with urinary incontinence: reliability, validity and responsiveness. Quality of Life Research, 17(3), 475–483.
Husted, J. A., Cook, R. J., Farewell, V. T., & Gladman, D. D. (2000). Methods for assessing responsiveness: a critical review and recommendations. Journal of Clinical Epidemiology, 53(5), 459–468.
Kind, P., Dolan, P., Gudex, C., & Williams, A. (1998). Variations in population health status: results from a United Kingdom national questionnaire survey. British Medical Journal, 316(7133), 736.
Macfarlane, J. T., Macfarlane, R. M., Rose, D. H., Colville, A., & Guion, A. (1993). Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. The Lancet, 341(8844), 511–514.
McTaggart-Cowan, H. M., Marra, C. A., Yang, Y., Brazier, J. E., Kopec, J. A., FitzGerald, J. M., et al. (2008). The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Quality of Life Research, 17(3), 453–462.
Mulder, I., Tijhuis, M., Smit, A., & Kromhout, D. (2001). Smoking cessation and quality of life: the effect of amount of smoking and time since quitting. Preventive Medicine, 33, 653–660.
Oga, T., Nishimura, K., Tsukino, M., Sato, S., Hajiro, T., & Mishima, M. (2003). A comparison of the responsiveness of different generic health status measures in patients with asthma. Quality of Life Research, 12(5), 555–63.
Oppong, R., Coast, J., Hood, K., Nuttall, J., Smith, R. D., & Butler, C. C. (2010). Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges. The European Journal of Health Economics 1–11 doi:10.1007/s10198-101-0239-1
Pickard, A., Wilke, C., Jung, E., Patel, S., Stavem, K., & Lee, T. A. (2008). Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respiratory Medicine, 102(4), 519–536.
Rutten-van Mölken, M. P. M. H., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., & Monz, B. U. (2006). Does quality of life of COPD patients as measured by the generic euroQol five-dimension questionnaire differentiate between COPD severity stages?*. Chest, 130(4), 1117.
Sculpher, M. (2008). NICE’s 2008 methods guide sensible consolidation or opportunities missed? Pharmacoeconomics, 26(9), 721–724.
Stanton, N., Hood, K., Kelly, M. J., Nuttall, J., Gillespie, D., Verheij, T., et al. (2009). Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit?-An observational study in 13 European countries. European Respiratory Journal 09031936-00168409
Streiner, D. L., & Norman, G. R. (2003). Health measurement scales. A practical guide to their development and use.
Sullivan, P. W., & Ghushchyan, V. (2006). Preference-based EQ-5D index scores for chronic conditions in the United States. Medical Decision Making, 26(4), 410.
The EuroQol Group. (1990). EuroQol-a new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208.
Torrance, G. W., Tugwell, P., Amorosi, S., Chartash, E., & Sengupta, N. (2004). Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate. Rheumatology, 43(6), 712.
Van Duijn, H. J., Kuyvenhoven, M. M., Butler, C. C., Coenen, S., & Verheij, T. J. M. (2005). Variation in outpatient antibiotic use in three European countries: exploration of possible determinants. European Journal of General Practice, 11(3/4), 139.
Venmans, et al. (2008). Prediction of complicated lower respiratory tract infections in older patients with diabetes. British Journal of General Practice, 58(553), 564–568.
Watson, L., Little, P., Moore, M., Warner, G., & Williamson, I. (2001). Validation study of a diary for use in acute lower respiratory tract infection. Family Practice, 18(5), 553.
Williams, J. V., Harris, P. A., Tollefson, S. J., Halburnt-Rush, L. L., Pingsterhaus, J. M., Edwards, K. M., et al. (2004). Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. New England Journal of Medicine, 350(5), 443.
Acknowledgements
This study was funded as part of the GRACE (Genomics to combat resistance against antibiotics in community-acquired LRTI in Europe), a European Commission funded project within the Sixth Framework Programme, reference number LSHM-CT-2005-518226.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Oppong, R., Kaambwa, B., Nuttall, J. et al. Assessment of the Construct Validity of the EQ-5D in Patients with Acute Cough/Lower Respiratory Tract Infections. Applied Research Quality Life 6, 411–423 (2011). https://doi.org/10.1007/s11482-011-9137-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11482-011-9137-7